Trusted News Discovery Since 2008
{{/content}}
Content posted against Serum Institute of India prima facie defamatory: HC
Credit: Mid-Day- Published on June 5, 2023
The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly posting erroneous content against the company and its COVID-19 vaccine Covishield
You are here
Related news from verified sources
The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)...
on June 5, 2023 • Mid-Day